The University of Colorado Denver is a public research university in Denver. It is part of the University of Colorado system.

During the past decade, University of Colorado Health Sciences Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 24 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Colorado Health Sciences Center" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 69 trials, followed by "University of Colorado, Denver" with 31 trials sponsored, "Gilead Sciences" with 7 trials sponsored, "Actelion" with 6 trials sponsored and "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials sponsored. Other sponsors include 117 different institutions and companies that sponsored additional 87 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Colorado Health Sciences Center" #1 collaborator was "Bristol-Myers Squibb" with 12 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 11 trials as a collaborator, "Glaxo Wellcome" with 9 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 9 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 7 trials as a collaborator. Other collaborators include 126 different institutions and companies that were collaborators in the rest 98 trials.

According to Clinical.Site data, the most researched conditions in "University of Colorado Health Sciences Center" are "HIV Infections" (104 trials), "Hepatitis C" (6 trials), "Heroin Dependence" (6 trials), "Opioid-Related Disorders" (6 trials) and "Pulmonary Hypertension" (6 trials). Many other conditions were trialed in "University of Colorado Health Sciences Center" in a lesser frequency.

Most popular intervention types in "University of Colorado Health Sciences Center" are "Drug" (168 trials), "Behavioral" (23 trials), "Procedure" (12 trials), "Other" (9 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (22 trials), "Didanosine" (19 trials), "Lamivudine" (16 trials), "Placebo" (16 trials) and "Indinavir sulfate" (15 trials). Other intervention names were less common.

The vast majority of trials in "University of Colorado Health Sciences Center" are 223 trials for "All" genders, 9 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "University of Colorado Health Sciences Center". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 197 completed trials in University of Colorado Health Sciences Center, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in University of Colorado Health Sciences Center, 26 "Phase 1" clinical trials were conducted, 88 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 35 trials that are defined as “Not Applicable".